Navigation Links
Renal function and heart disease, and more
Date:9/3/2007

In this weeks press release:

  • Renal function and coronary heart disease
  • Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1

Please mention PLoS Medicine in your report and use the links below to take your readers straight to the online articles:


THE FOLLOWING RESEARCH ARTICLES WILL BE PUBLISHED ONLINE:

Renal function and coronary heart disease

John Danesh and colleagues conclude there may be a moderate increase in risk of coronary heart disease associated with very low estimated glomerular filtration rate.

Citation: Di Angelantonio E, Danesh J, Eiriksdottir G, Gudnason V (2007) Renal function and risk of coronary heart disease in general populations: New prospective study and systematic review. PLoS Med 4(9): e270.

IN YOUR ARTICLE, PLEASE LINK TO THIS URL, WHICH WILL PROVIDE ACCESS TO THE PUBLISHED PAPER: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040270

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-04-09-danesh.pdf

CONTACT:

John Danesh
University of Cambridge
Institute of Public Health
Dept of Public Health and Primary Care
Strangeways Research Laboratory
Worts Causeway
Cambridge, CB1 8RN
United Kingdom
+44 1223 741302
+44 1223 741339 (fax)
john.danesh@phpc.cam.ac.uk


Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1

Using a mouse model of acute respiratory distress syndrome, Duncan Stewart and colleagues report that rescue with mesenchymal stem cells expressing human angiopoietin 1 can avert lung injury from lipopolysaccharide.

Citation: Mei SHJ, McCarter SD, Deng Y, Parker CH, Liles WC, et al. (2007) Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4(9): e269.

IN YOUR ARTICLE, PLEASE LINK TO THIS URL, WHICH WILL PROVIDE ACCESS TO THE PUBLISHED PAPER: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040269

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-04-09-stewart.pdf

CONTACT:

Duncan Stewart
University of Toronto
St. Michaels Hospital
The Terrence Donnelly Research Laboratories
Toronto, Ontario
Canada
+1 416 864-5724
dustewart@ohri.ca
'/>"/>

Contact: Andrew Hyde
ahyde@plos.org
44-122-346-3330
Public Library of Science
Source:Eurekalert

Related medicine news :

1. Renal problem alleviated
2. Increase in renal problems
3. Effect of drug on Renal Cancer
4. Renal problem increased
5. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
6. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
7. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
8. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
9. Clinical Renal Trails Do Not Have Sufficient Women Participants
10. Adrenal Suppression not predicted by inhaled corticosteroids
11. Sunitinib a Promising Agent for Treatment of Renal Cell Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between ... they no longer use or need, from clothes to couches to dressers and bicycles. ... and take them to the nearest Goodwill donation center through February 28th. , ...
(Date:1/20/2017)... Miami, Florida (PRWEB) , ... January 20, 2017 , ... ... in head lice cases in families with school-aged children since the holiday season. ... spend the holidays with their families, sharing hugs and taking photos, which is the ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... its sugar-free alternative VW+ 002. The drinks have been produced in collaboration with ... to perform during your workout. , After a successful launch in Sweden last ...
(Date:1/20/2017)... ... 2017 , ... D R Burton Healthcare Products LLC, makers ... in a study indicating superior performance against competitive products in secretion clearance. ... Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter issue ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All Odds”: an ... of published author, Keith C. A. Tucker, son of Minister Delores Pinnock and a ... by Reverend Mark Hardy , “While sitting up in bed, I felt a pounding ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
Breaking Medicine Technology: